240 related articles for article (PubMed ID: 20087685)
21. Immuno-informatics based approaches to identify CD8+ T cell epitopes within the Leishmania donovani 3-ectonucleotidase in cured visceral leishmaniasis subjects.
Vijayamahantesh ; Amit A; Dikhit MR; Singh AK; Venkateshwaran T; Das VNR; Das P; Bimal S
Microbes Infect; 2017 Jun; 19(6):358-369. PubMed ID: 28373107
[TBL] [Abstract][Full Text] [Related]
22. Making an anti-amastigote vaccine for visceral leishmaniasis: rational, update and perspectives.
Fernandes AP; Coelho EA; Machado-Coelho GL; Grimaldi G; Gazzinelli RT
Curr Opin Microbiol; 2012 Aug; 15(4):476-85. PubMed ID: 22698479
[TBL] [Abstract][Full Text] [Related]
23. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
[TBL] [Abstract][Full Text] [Related]
24. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
Reiner NE
J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
[TBL] [Abstract][Full Text] [Related]
25. Macrophages, pathology and parasite persistence in experimental visceral leishmaniasis.
Engwerda CR; Ato M; Kaye PM
Trends Parasitol; 2004 Nov; 20(11):524-30. PubMed ID: 15471704
[TBL] [Abstract][Full Text] [Related]
26. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis.
Basu R; Bhaumik S; Basu JM; Naskar K; De T; Roy S
J Immunol; 2005 Jun; 174(11):7160-71. PubMed ID: 15905560
[TBL] [Abstract][Full Text] [Related]
27. Differential Induction of SOCS Isoforms by
Chandrakar P; Parmar N; Descoteaux A; Kar S
J Immunol; 2020 Feb; 204(3):596-610. PubMed ID: 31882519
[TBL] [Abstract][Full Text] [Related]
28. Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype.
Andreani G; Ouellet M; Menasria R; Gomez AM; Barat C; Tremblay MJ
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003543. PubMed ID: 25710789
[TBL] [Abstract][Full Text] [Related]
29. Vaccination with leishmania hemoglobin receptor-encoding DNA protects against visceral leishmaniasis.
Guha R; Gupta D; Rastogi R; Vikram R; Krishnamurthy G; Bimal S; Roy S; Mukhopadhyay A
Sci Transl Med; 2013 Sep; 5(202):202ra121. PubMed ID: 24027025
[TBL] [Abstract][Full Text] [Related]
30. Reduced pathogenicity of fructose-1,6-bisphosphatase deficient Leishmania donovani and its use as an attenuated strain to induce protective immunogenicity.
Saini S; Ghosh AK; Das S; Singh R; Abhishek K; Verma S; Kumar A; Mandal A; Purkait B; Sinha KK; Das P
Vaccine; 2018 Feb; 36(9):1190-1202. PubMed ID: 29395522
[TBL] [Abstract][Full Text] [Related]
31. Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.
Polley R; Sanos SL; Prickett S; Haque A; Kaye PM
Infect Immun; 2005 Dec; 73(12):7996-8001. PubMed ID: 16299292
[TBL] [Abstract][Full Text] [Related]
32. Leishmania donovani mediated higher expression of CCL4 induces differential accumulation of CD4
Kumari S; Shivam P; Kumar S; Jamal F; Singh MK; Bimal S; Narayan S; Pandey K; Das VNR; Das P; Singh SK
Cytokine; 2018 Oct; 110():306-315. PubMed ID: 29807685
[TBL] [Abstract][Full Text] [Related]
33. T cell suppression in the bone marrow of visceral leishmaniasis patients: impact of parasite load.
Kumar P; Misra P; Thakur CP; Saurabh A; Rishi N; Mitra DK
Clin Exp Immunol; 2018 Mar; 191(3):318-327. PubMed ID: 29058314
[TBL] [Abstract][Full Text] [Related]
34. The impact of IL-10 dynamic modulation on host immune response against visceral leishmaniasis.
Mesquita I; Ferreira C; Barbosa AM; Ferreira CM; Moreira D; Carvalho A; Cunha C; Rodrigues F; Dinis-Oliveira RJ; Estaquier J; Castro AG; Torrado E; Silvestre R
Cytokine; 2018 Dec; 112():16-20. PubMed ID: 30017388
[TBL] [Abstract][Full Text] [Related]
35. Live Attenuated
Banerjee A; Bhattacharya P; Dagur PK; Karmakar S; Ismail N; Joshi AB; Akue AD; KuKuruga M; McCoy JP; Dey R; Nakhasi HL
J Immunol; 2018 Jan; 200(1):163-176. PubMed ID: 29187586
[TBL] [Abstract][Full Text] [Related]
36. Visceral leishmaniasis in congenic mice of susceptible and resistant phenotypes: immunosuppression by adherent spleen cells.
Nickol AD; Bonventre PF
Infect Immun; 1985 Oct; 50(1):160-8. PubMed ID: 2931376
[TBL] [Abstract][Full Text] [Related]
37. Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani.
McFarlane E; Perez C; Charmoy M; Allenbach C; Carter KC; Alexander J; Tacchini-Cottier F
Infect Immun; 2008 Feb; 76(2):532-41. PubMed ID: 18056477
[TBL] [Abstract][Full Text] [Related]
38. Genetically Engineered Ascorbic acid-deficient Live Mutants of Leishmania donovani induce long lasting Protective Immunity against Visceral Leishmaniasis.
Anand S; Madhubala R
Sci Rep; 2015 Jun; 5():10706. PubMed ID: 26035062
[TBL] [Abstract][Full Text] [Related]
39. Induction of protective cellular immune responses against experimental visceral leishmaniasis mediated by dendritic cells pulsed with the N-terminal domain of Leishmania infantum elongation factor-2 and CpG oligodeoxynucleotides.
Agallou M; Pantazi E; Tsiftsaki E; Toubanaki DK; Gaitanaki C; Smirlis D; Karagouni E
Mol Immunol; 2018 Nov; 103():7-20. PubMed ID: 30173073
[TBL] [Abstract][Full Text] [Related]
40. IFN-γ
Yadav S; Prakash J; Singh OP; Gedda MR; Chauhan SB; Sundar S; Dubey VK
Cell Immunol; 2021 Mar; 361():104272. PubMed ID: 33445051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
